ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,160,000 | -8.9% | 70,900 | +34.8% | 0.02% | -20.0% |
| Q1 2022 | $1,274,000 | -5.1% | 52,611 | -8.6% | 0.02% | -28.6% |
| Q4 2021 | $1,343,000 | -7.8% | 57,560 | -3.6% | 0.04% | +29.6% |
| Q2 2021 | $1,456,000 | +52.6% | 59,698 | +61.5% | 0.03% | +68.8% |
| Q1 2021 | $954,000 | -70.6% | 36,976 | -53.0% | 0.02% | -83.5% |
| Q3 2020 | $3,242,000 | -14.9% | 78,600 | 0.0% | 0.10% | -46.7% |
| Q2 2020 | $3,810,000 | – | 78,600 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |